News|Articles|March 17, 2025
Retraction: Water-Free Topical Cyclosporine Improved Dryness Score in Dry Eye
Author(s)Julia Bonavitacola
Listen
0:00 / 0:00
Key Takeaways
- The study on topical cyclosporine contained calculation errors affecting its conclusions.
- Authors requested a temporary retraction to review and correct inaccuracies.
Advertisement
The American Journal of Managed Care has been informed that this previous study held several inaccuracies regarding topical cyclosporine, including calculation errors that could have affected the study's conclusions.
At the request of the authors, we are temporarily retracting the news article until inaccuracies in the data published are reviewed and corrected.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
CLL Breakthrough: 100% Efficacy Reported for VenR Retreatment
2
AAP Breaks With CDC, Maintains Broader 2026 Childhood and Adolescent Vaccine Schedule
3
Trulicity, Botox Headline Drugs Included in the Third Cycle of Medicare Price Negotiations
4
Combination Therapy, Biologics, and Surgery Redefine HS Care in 2026
5
